Celldex Therapeutics Inc (CLDX)
36.14
-0.12
(-0.32%)
USD |
NASDAQ |
Apr 26, 10:08
Celldex Therapeutics Revenue (TTM): 6.883M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.883M |
| September 30, 2023 | 4.365M |
| June 30, 2023 | 3.255M |
| March 31, 2023 | 3.15M |
| December 31, 2022 | 2.357M |
| September 30, 2022 | 1.078M |
| June 30, 2022 | 0.824M |
| March 31, 2022 | 4.141M |
| December 31, 2021 | 4.652M |
| September 30, 2021 | 8.103M |
| June 30, 2021 | 8.618M |
| March 31, 2021 | 5.374M |
| December 31, 2020 | 7.417M |
| September 30, 2020 | 4.519M |
| June 30, 2020 | 4.397M |
| March 31, 2020 | 4.876M |
| December 31, 2019 | 3.573M |
| September 30, 2019 | 4.45M |
| June 30, 2019 | 4.845M |
| March 31, 2019 | 6.893M |
| December 31, 2018 | 9.536M |
| September 30, 2018 | 11.23M |
| June 30, 2018 | 14.21M |
| March 31, 2018 | 15.28M |
| December 31, 2017 | 12.74M |
| Date | Value |
|---|---|
| September 30, 2017 | 11.16M |
| June 30, 2017 | 9.456M |
| March 31, 2017 | 7.016M |
| December 31, 2016 | 6.785M |
| September 30, 2016 | 6.703M |
| June 30, 2016 | 5.509M |
| March 31, 2016 | 6.298M |
| December 31, 2015 | 5.481M |
| September 30, 2015 | 5.167M |
| June 30, 2015 | 5.242M |
| March 31, 2015 | 3.656M |
| December 31, 2014 | 3.586M |
| September 30, 2014 | 2.729M |
| June 30, 2014 | 2.608M |
| March 31, 2014 | 2.113M |
| December 31, 2013 | 4.111M |
| September 30, 2013 | 7.138M |
| June 30, 2013 | 9.271M |
| March 31, 2013 | 11.18M |
| December 31, 2012 | 11.20M |
| September 30, 2012 | 9.989M |
| June 30, 2012 | 9.239M |
| March 31, 2012 | 9.182M |
| December 31, 2011 | 9.265M |
| September 30, 2011 | 44.55M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.824M
Minimum
Jun 2022
8.618M
Maximum
Jun 2021
4.572M
Average
4.45M
Median
Sep 2019
Revenue (TTM) Benchmarks
| ThermoGenesis Holdings Inc | 9.445M |
| Perspective Therapeutics Inc | 0.00 |
| Electromed Inc | 51.69M |
| Xtant Medical Holdings Inc | 91.30M |
| Asensus Surgical Inc | 8.577M |